Third phase human trial of COVID-19 vaccine to commence in Bhubaneswar soon : The Tribune India

Join Whatsapp Channel

Third phase human trial of COVID-19 vaccine to commence in Bhubaneswar soon

The search for a suitable vaccine for COVID-19 has almost come to the final stage

Third phase human trial of COVID-19 vaccine to commence in Bhubaneswar soon

The search for a suitable vaccine for COVID-19 has almost come to the final stage. Reuters photo.



Bhubaneswar, October 26  

The third phase of the human trial of the indigenous vaccine against COVID-19, COVAXIN, will commence at a private hospital here soon, an official said.

The search for a suitable vaccine for COVID-19 has almost come to the final stage, Dr E Venkata Rao, Principal Investigator in the COVAXIN human trial and Professor in the Department of Community Medicine at the Institute of Medical Sciences and SUM Hospital here said on Sunday.

IMS and SUM Hospital is among the 21 medical institutes selected across the country by the Indian Council for Medical Research (ICMR) where the third phase trial would be conducted.

The indigenous vaccine, being developed by ICMR and Bharat Biotech has received the approval of the Central Drugs Standard Control Organisation (CDSCO) for initiating the third phase trial. After completion of the first and second phase of the trial with demonstrable safety profile and immunogenicity, the large-scale efficacy trial involving thousands of volunteers has been planned now, Dr Rao said.

Dr Rao, who is the head of the Preventive and Therapeutic Clinical Trial Unit (PTCTU), said during this phase the age limit and eligibility/ screening criteria would be relaxed and several volunteers who are otherwise apparently healthy would be recruited for the trial.

Like the previous phases, half of the volunteers would receive placebo and the remaining half would be administered COVAXIN in this phase. Even health care workers would be recruited for the trial. The volunteers would be followed up over a considerable period to look at the efficacy of the vaccine in preventing the development of the Corona disease, he said.

Rao said there had been a huge response and enthusiasm among people who had offered themselves to be volunteers for the trial. He said persons above 18 years will be taken for the human trial.

The interested volunteers for the project could enrol themselves for the trial by registering online at www.ptctu.soa.ac under the section register for clinical trials, he said. PTI 


Top News

Lok Sabha election 2024: Voting under way in 88 constituencies; Rahul Gandhi, Hema Malini in fray

Nearly 61 per cent turnout in Phase 2 of Lok Sabha polls; Tripura records 78.53 per cent, Manipur 77.18 Nearly 61 per cent turnout in Phase 2 of Lok Sabha polls; Tripura records 78.53 per cent, Manipur 77.18

The Election Commission says polling remained largely peacef...

Arvind Kejriwal as CM even after arrest puts political interest over national interest: Delhi High Court

Arvind Kejriwal as CM even after arrest puts political interest over national interest: Delhi High Court

The court says the Delhi government is ‘interested in approp...

Amritpal Singh to contest Lok Sabha poll from Punjab’s Khadoor Sahib, confirms mother

Amritpal Singh to contest Lok Sabha poll from Punjab’s Khadoor Sahib, confirms mother

The formal announcement is made by his mother Balwinder Kaur...

Supreme Court to deliver verdict on PILs seeking 100 per cent cross-verification of EVM votes with VVPAT today

Supreme Court dismisses PILs seeking 100% cross-verification of EVM votes with VVPAT slips

Bench however, issues certain directions to Election Commiss...

Will stop functioning in India if made to break encryption of messages: WhatsApp to Delhi High Court

Will stop functioning in India if made to break encryption of messages: WhatsApp to Delhi High Court

Facebook and Whatsapp have recently challenged the new rules...


Cities

View All